Grassley, Klobuchar Propose Importation For Low-Competition Drugs

March 15, 2019
A bipartisan group of senators, including Senate Finance Committee Chair Chuck Grassley (R-IA) and Sen. Amy Klobuchar (D-MN), reintroduced a bill Friday (March 15) to allow temporary importation of prescription drugs that are in shortage or have fewer than five competitors. In cases of low competition, drugs would have to be approved for at least 10 years before allowing imports. Drugs could only be imported from countries with drug-approval standards to those in the United States. The Short on Competition...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.